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**Abstract**

**Background:** Somatostatin (SST) deficits are common features in neurological disorders with mood disturbances, but little is known about the contribution or cause of these deficits to mood symptoms.

**Methods:** Human postmortem molecular and animal genetic/pharmacological studies.

**Results:** Results from human postmortem brains demonstrate molecular changes affecting SST-positive GABA neurons in depression. The mouse genetic studies suggest that low SST and reduced SST-positive GABA neurons have causal roles in generating illness symptoms and are targets for novel antidepressant modalities. Specifically, we show that mice lacking Sst exhibit elevated behavioral emotionality, high basal plasma corticosterone and reduced gene expression that recapitulate behavioral, neuroendocrine and molecular features of human depression. Using laser-capture microdissection, we show that cortical SST-positive interneurons display greater transcriptome deregulations after chronic stress compared to pyramidal neurons. Protein translation through eukaryotic initiation factor 2 (EIF2) signaling, a pathway implicated in neurodegenerative diseases, was most affected and suppressed in stress-exposed SST neurons. We show that activating EIF2 signaling through EIF2 kinase inhibition mitigated stress-induced behavioral emotionality in mice. Finally, as the function of SST-positive GABA neurons is mediated by post-synaptic GABA-A receptors containing the alpha5 subunit, we show that boosting Alpha5-mediated GABA function (through positive allosteric modulation) has antidepressant activity in chronically stress mice.

**Conclusions:** The data presented suggest that (1) low SST plays a causal role in mood-related phenotypes, (2) deregulated EIF2-mediated protein translation may represent a mechanism for vulnerability of SST neurons, (3) global EIF2 signaling has antidepressant/anxiolytic potential, and (4) boosting postsynaptic SST-positive GABA neuron signaling has antidepressant/anxiolytic potential.

**Results**: A summary of the results of the study, including sufficient details to support those conclusions. Include number of subjects and relevant statistics, and a clear statement about the novel and unpublished findings that will be presented. **Abstract**s with "results promised at a later date" will receive lower scores. These may be presented in a brief table. Data must be provided. **Abstract**s stating "data will be provided at a later date" will be not be considered.

**Conclusions**: A statement concerning the significance of the work and its possible implications for future research.
